Updated Date: Fri, 17 Feb 2023 00:00:00 EST

Updated Date: Fri, 17 Feb 2023 00:00:00 EST

Updated Date: Fri, 17 Feb 2023 00:00:00 EST

Africa-based trials for blood test which detects risk of disease progression are due to begin

Treatment is an BTK inhibitor and has demonstrated a sound safety and tolerability profile

Phase 1/2 research shows that treatment could be very effective against Fabry disease

Next phase of Newel Health’s digital therapeutics solution for Parkinson’s disease gains vital grant

New top line data has emerged from the company’s phase 1b study evaluating potential for treating sepsis

Research will analyse how Huawei’s wearable technology detects atrial fibrillation in post-stroke patients

Updated Date: Tue, 14 Feb 2023 00:00:00 EST